These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase. Tallima H, Dvořák J, Kareem S, Abou El Dahab M, Abdel Aziz N, Dalton JP, El Ridi R. PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516 [Abstract] [Full Text] [Related]
5. Specific Antibodies and Arachidonic Acid Mediate the Protection Induced by the Schistosoma mansoni Cysteine Peptidase-Based Vaccine in Mice. Tallima H, Abou El Dahab M, El Ridi R. Vaccines (Basel); 2020 Nov 16; 8(4):. PubMed ID: 33207535 [Abstract] [Full Text] [Related]
9. Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice. Morais SB, Figueiredo BC, Assis NRG, Homan J, Mambelli FS, Bicalho RM, Souza C, Martins VP, Pinheiro CS, Oliveira SC. Front Immunol; 2018 Nov 16; 9():1762. PubMed ID: 30105029 [Abstract] [Full Text] [Related]
10. Arachidonic Acid Is a Safe and Efficacious Schistosomicide, and an Endoschistosomicide in Natural and Experimental Infections, and Cysteine Peptidase Vaccinated Hosts. Tallima H, Hanna VS, El Ridi R. Front Immunol; 2020 Nov 16; 11():609994. PubMed ID: 33281832 [Abstract] [Full Text] [Related]
11. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. El Ridi R, Tallima H. Vaccine; 2009 Jan 29; 27(5):666-73. PubMed ID: 19056448 [Abstract] [Full Text] [Related]
12. Immunogenicity and vaccine potential of dipeptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. El Ridi R, Montash M, Tallima H. Scand J Immunol; 2004 Oct 29; 60(4):392-402. PubMed ID: 15379864 [Abstract] [Full Text] [Related]
13. A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis. Ricciardi A, Visitsunthorn K, Dalton JP, Ndao M. BMC Infect Dis; 2016 Mar 05; 16():112. PubMed ID: 26945988 [Abstract] [Full Text] [Related]
16. Schistosoma mansoni egg-derived extracellular vesicles: A promising vaccine candidate against murine schistosomiasis. Mossallam SF, Abou-El-Naga IF, Abdel Bary A, Elmorsy EA, Diab RG. PLoS Negl Trop Dis; 2021 Oct 05; 15(10):e0009866. PubMed ID: 34644290 [Abstract] [Full Text] [Related]
17. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice. Ahmad G, Zhang W, Torben W, Noor Z, Siddiqui AA. Int J Infect Dis; 2010 Sep 05; 14(9):e781-7. PubMed ID: 20630783 [Abstract] [Full Text] [Related]
18. Immunization of mice with crude extract of Saccharomyces boulardii yeast induces cross-reactive immune responses with antigenic preparations from different developmental stages of the Schistosoma mansoni and reduces the parasite worm burden. Bahgat M, Maghraby AS, Ab Del-Fatah OM, Elshafei AM. J Egypt Soc Parasitol; 2005 Aug 05; 35(2):563-80. PubMed ID: 16083068 [Abstract] [Full Text] [Related]